- Last edited on September 4, 2023
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
geri:dementia:progressive-supranuclear-palsy-psp [on September 16, 2018] |
geri:dementia:progressive-supranuclear-palsy-psp [on June 2, 2019] |
||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Progressive Supranuclear Palsy (PSP) ====== | ||
+ | {{INLINETOC}} | ||
+ | ===== Primer ===== | ||
+ | **Progressive Supranuclear Palsy** (PSP) is a neurodegenerative disorder characterized by early postural instability, leading to falls, and a characteristic vertical supranuclear-gaze palsy on physical exam. It is classified as an atypical parkinsonian syndrome (or Parkinson's Plus). | ||
+ | |||
+ | == Symptoms == | ||
+ | Pseudobulbar signs may be present, and retropulsion is often prominent. Cognitive testing will show psychomotor slowing, poor working memory, and executive dysfunction. | ||
+ | ===== Diagnostic Criteria ===== | ||
+ | |||
+ | ==== NINDS-SPSP Criteria ==== | ||
+ | The National Institute of Neurological Disorders and Stroke and Society for PSP (NINDS-SPSP) criteria are the most widely used criteria for the diagnosis of PSP.[([[https://www.ncbi.nlm.nih.gov/pubmed/8710059|Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., ... & Hallett, M. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) report of the NINDS-SPSP international workshop. Neurology, 47(1), 1-9.]])] | ||
+ | |||
+ | <panel type="info" title=" NINDS-SPSP PSP Criteria" subtitle="Litvan, I., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) report of the NINDS-SPSP international workshop. Neurology 47.1 (1996): 1-9." no-body="true"> | ||
+ | |||
+ | ^ ^ Symptoms ^ | ||
+ | ^ Probable PSP | Vertical supranuclear gaze palsy plus postural instability and falls within the first year of symptom onset to diagnosis. | | ||
+ | ^ Possible PSP | Supranuclear gaze palsy or a combination of slow vertical saccades and postural instability with falls within the first year. | | ||
+ | </panel> | ||
+ | |||
+ | ==== MDS Criteria ==== | ||
+ | The International Parkinson and Movement Disorder Society (MDS)-endorsed PSP Study Group set out to provide an evidence and consensus-based revision of the NINDS-SPSP criteria in 2017, with a much more comprehensive set of criteria.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516529/|Hoglinger, Gunter U. et al. “Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria.” Movement disorders : official journal of the Movement Disorder Society 32.6 (2017): 853–864. PMC. Web. 16 Sept. 2018.]])] | ||
+ | |||
+ | <panel type="info" title="Basic Features: Core Inclusion and Exclusion Criteria" subtitle="Höglinger, Günter U., et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Movement Disorders 32.6 (2017): 853-864." no-body="true"> | ||
+ | ^ Mandatory inclusion criteria | 1. Sporadic occurrence \\ 2. Age 40 or older at onset of first PSP-related symptom \\ 3. Gradual progression of PSP-related symptoms | | ||
+ | ^ Mandatory exclusion criteria | //Clinical findings//\\ 1. Predominant, otherwise unexplained impairment of episodic memory, suggestive of [[geri:dementia:alzheimers|]]\\ 2. Predominant, otherwise unexplained autonomic failure, e.g., orthostatic hypotension (orthostatic reduction in blood pressure after 3 minutes standing 30 mm Hg systolic or 15 mm Hg diastolic), suggestive of multiple system atrophy or Lewy body disease\\ 3. Predominant, otherwise unexplained visual hallucinations or fluctuations in alertness, suggestive of dementia with Lewy bodies\\ 4. Predominant, otherwise unexplained multisegmental upper and lower motor neuron signs, suggestive of motor neuron disease (pure upper motor neuron signs are not an exclusion criterion)\\ 5. Sudden onset or step-wise or rapid progression of symptoms, in conjunction with corresponding imaging or laboratory findings, suggestive of vascular etiology, autoimmune encephalitis, metabolic encephalopathies, or prion disease \\ 6. History of encephalitis\\ 7. Prominent appendicular ataxia\\ 8. Identifiable cause of postural instability, e.g., primary sensory deficit, vestibular dysfunction,\\ severe spasticity, or lower motor neuron syndrome \\ \\ //Imaging findings//\\ 1. Severe leukoencephalopathy, evidenced by cerebral imaging\\ 2. Relevant structural abnormality, e.g., normal pressure or obstructive hydrocephalus; basal ganglia, diencephalic, mesencephalic, pontine or medullary infarctions, hemorrhages, hypoxic-ischemic lesions, tumors, or malformations | | ||
+ | </panel> | ||
+ | |||
+ | |||
+ | <panel type="info" title="Core Clinical Features" subtitle="Höglinger, Günter U., et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Movement Disorders 32.6 (2017): 853-864." footer="Presumed levels of certainty (1 [highest], 2 [mid], and 3 [lowest]) that contribute to the diagnosis of PSP" no-body="true"> | ||
+ | ^ Levels of Certainty ^ Ocular Motor Dysfunction ^ Postural Instability ^ Akinesia ^ Cognitive Dysfunction ^ | ||
+ | ^ Level 1 | **O1**: Vertical supranuclear gaze palsy | **P1**: Repeated unprovoked falls within 3 years | **A1**: Progressive gait freezing\\ within 3 years | **C1**: Speech/language disorder (i.e. - nonfluent/agrammatic variant of [[geri:dementia:primary-progressive-aphasia-ppa|primary progressive aphasia]] or progressive apraxia of speech) | | ||
+ | ^ Level 2 | **O2**: Slow velocity of vertical saccades | **P2**: Tendency to fall on the pull-test within 3 year | **A2**: [[geri:parkinsons|Parkinsonism]], akinetic-rigid,\\ predominantly axial, and\\ levodopa resistant | **C2**: [[geri:dementia:frontotemporal|Frontal cognitive/behavioural presentation]] | | ||
+ | ^ Level 3 | **O3**: Frequent macro square wave jerks or\\ "eyelid opening apraxia" | **P3**: More than two steps backward on the pull-test within 3 years | **A3**: [[geri:parkinsons|Parkinsonism]], with tremor and/or asymmetric and/or levodopa responsive | **C3**: [[geri:dementia:corticobasal-degeneration-cbd|Corticobasal syndrome]] | | ||
+ | </panel> | ||
+ | ===== Pathophysiology ===== | ||
+ | PSP is due to the intracerebral aggregation of the microtubule-associated protein tau (MAPT), predominantly involving isoforms with four microtubule-binding repeats (4R-tau), in neurofibrillary tangles, oligoden- drocytic coils, and, specifically, astrocytic tufts. The definite diagnosis of PSP requires a post-mortem neuropathological examination. |